Sm04554

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Tenma
    Senior Member
    • Nov 2013
    • 172

    Im not very familiarized with US law but find really unlikely this act will speed up clinical trials for hairloss drugs.

    Comment

    • burtandernie
      Senior Member
      • Nov 2012
      • 1568

      Yeah a lot of talk about this bill but no one has any clue what it will really do for specific drugs until they actually start altering timelines and there is a basis to start guessing at other ones. Right now it might not do anything at all for cosmetic drugs. No one knows. I wouldnt count on politicians or laws they pass to do much of anything in speeding up trials. Waiting on new treatments for many years is the worst part of the whole thing especially stuff like CB when there are millions of previous AAs some with similar actions to base safety off of yet 5 years to finish it? I doubt getting a topical delivery system takes that long to do. The phase 3 just kills huge amounts of time and money

      Comment

      • joel203
        Senior Member
        • Jun 2014
        • 115

        Originally posted by Tenma
        Im not very familiarized with US law but find really unlikely this act will speed up clinical trials for hairloss drugs.
        agreed

        Comment

        • It's2014ComeOnAlready
          Senior Member
          • Sep 2014
          • 584

          Originally posted by burtandernie
          Yeah a lot of talk about this bill but no one has any clue what it will really do for specific drugs until they actually start altering timelines and there is a basis to start guessing at other ones. Right now it might not do anything at all for cosmetic drugs. No one knows. I wouldnt count on politicians or laws they pass to do much of anything in speeding up trials. Waiting on new treatments for many years is the worst part of the whole thing especially stuff like CB when there are millions of previous AAs some with similar actions to base safety off of yet 5 years to finish it? I doubt getting a topical delivery system takes that long to do. The phase 3 just kills huge amounts of time and money
          I don't think it's OK to speculate one way or another. You all seem to go according to your mood. The bottom line is that this law will change some protocol for clinical trials in general. They want to add information, i.e. biomarkers and surrogate endpoints. This is as much a health bill as it is an economic one. The point of the bill is also meant to keep innovation in the United States.

          Of course all of you believe hair loss will be left out. It's all I hear about on this board. How about keeping a positive outlook for once?

          Enough talk, let's just wait and see.

          Comment

          • lacazette
            Senior Member
            • May 2015
            • 396

            I read some various articles, saying that the new laws will give so much more freedom to pharma companies and that it will be very dangerous for the safety of the population. And that it would be better to stay like this without especially the suppression of the long phase 3 replaced by biomarkers,etc

            So if the bill pass, I don't see why we should be afraid for hairloss drugs as the other cosmetic areas. pharma freedom is all we need. And pharma lobbies are for sure already doing their job to make this bill passed, so no worries to have i think

            Comment

            • TooMuchHairWontKillYou
              Senior Member
              • Apr 2015
              • 104

              better worry about efficacy

              If SM fails I will get TE from depression

              Comment

              • nameless
                Senior Member
                • Feb 2013
                • 965

                Originally posted by joel203
                agreed

                I'm not 100% sure but I think you're probably wrong. I even think that the company believes that their drug will be affected by the new law or else the company would not bother trying to secure biomarkers through their additional phase 2 study. I think there's a very real possibility that they hope to use biomarkers in lieu of a phase 3.

                Comment

                • joel203
                  Senior Member
                  • Jun 2014
                  • 115

                  Originally posted by nameless
                  I'm not 100% sure but I think you're probably wrong. I even think that the company believes that their drug will be affected by the new law or else the company would not bother trying to secure biomarkers through their additional phase 2 study. I think there's a very real possibility that they hope to use biomarkers in lieu of a phase 3.
                  I hope you're right

                  Comment

                  • nameless
                    Senior Member
                    • Feb 2013
                    • 965

                    Originally posted by joel203
                    I hope you're right

                    Don't misquote me. I said I'm not 100% sure.

                    That having been said, I do not believe that the company intended to do the supplemental phase 2 from the beginning because if they had intended to do the supplemental phase 2 all along then it seems logical that they would have done it as part of the original phase 2. They could have gotten biopsies from their subjects in the original phase 2 study.

                    So this makes it look to me like this supplemental phase 2 study is something they only recently decided to do.

                    So the big question is what could have prompted them to do this ad-hoc study which will produce bio-markers? I think that the logical answer to that question is that they're aware of the new FDA law that allows drug companies to use bio-markers in lieu of a phase 3 study.

                    I also think that this ad-hoc study also makes it seem like they got good results in their original phase 2 study because why would they spend millions of dollars on the ad-hoc supplemental phase 2 study if they didn't see something promising in the original phase 2 study?

                    Comment

                    • lacazette
                      Senior Member
                      • May 2015
                      • 396

                      Agreed nameless

                      And I would add that they're surely planning to hit the asian market by japan's approval

                      The drug approval is already easier there, and even more easier when it comes to a topical drug instead of an oral
                      So I suspect a second phase 2 with detailed biomarkers could be sufficient to ask for Japan's FDA approval

                      Comment

                      • JayM
                        Senior Member
                        • Apr 2015
                        • 411

                        Originally posted by lacazette
                        Agreed nameless

                        And I would add that they're surely planning to hit the asian market by japan's approval

                        The drug approval is already easier there, and even more easier when it comes to a topical drug instead of an oral
                        So I suspect a second phase 2 with detailed biomarkers could be sufficient to ask for Japan's FDA approval
                        I thought Japan early release was only for stem cell therapies?

                        Comment

                        • lacazette
                          Senior Member
                          • May 2015
                          • 396

                          yeah the temp approval and new legislations are for regenerative medecine BUT when it comes to drugs approval, the process is also quicker and easier in Japan than US and EU

                          Comment

                          • champpy
                            Senior Member
                            • Apr 2015
                            • 348

                            Can anyone please answer this; if this latest SM trial is successful and they move to phase 3, how long does phase 3 for a hair loss med take?
                            I heard ppl say that bim could have moved through phase 3 in 6 months...is it the same timline for SM?
                            Is there anyway in hell this could be available in the next year (if it works of course)?

                            Comment

                            • allTheGoodNamesAreTaken
                              Senior Member
                              • Aug 2015
                              • 342

                              Originally posted by champpy
                              Can anyone please answer this; if this latest SM trial is successful and they move to phase 3, how long does phase 3 for a hair loss med take?
                              I heard ppl say that bim could have moved through phase 3 in 6 months...is it the same timline for SM?
                              Is there anyway in hell this could be available in the next year (if it works of course)?
                              Based on how slow EVERYTHING seems to move in this business I wouldn't count on the earliest possible release date turning out to be the actual one. Just assume it's gonna take ages to get released if it works at all.

                              Comment

                              • candu2015
                                Junior Member
                                • Oct 2015
                                • 4

                                hello it is the first time I write here but I have a lot of time reading to them.
                                Has anyone seen this trial about SM? https://www.anzctr.org.au/Trial/Regi...aspx?id=368801

                                why this trial in australia?

                                Comment

                                Working...